Ansbert Gadicke, M.D.
InvestorFounderChairman at MPM BioImpact · Board director at Reunion Neuroscience · Board director at Orna Therapeutics Holdings, LLC · Board director at iTeos Therapeutics
Boston, Massachusetts, United States
FoundedMpmcapital
Find your path to Ansbert
99 people in our graph share verified history with Ansbert — schools, employers, funds. One of them is your warm intro.
About
Chairman of MPM BioImpact with medical doctorate, involved in identifying and leading transformative therapeutic investments.
Board director at Reunion Neuroscience
Intro paths
In turn, Ansbert can intro founders to Reunion Neuroscience's investors below.
Board director at Orna Therapeutics Holdings, LLC
Intro paths
In turn, Ansbert can intro founders to Orna Therapeutics Holdings, LLC's investors below.
Orna Therapeutics Holdings, LLC's investors · 2
Co-founders at Orna Therapeutics Holdings, LLC

Board director at iTeos Therapeutics
Intro paths
In turn, Ansbert can intro founders to iTeos Therapeutics's investors below.
iTeos Therapeutics's investors · 10
Co-founders at iTeos Therapeutics

Experience
- MPM BioImpactManaging Partnercurrent1992 — present
Colleagues at MPM BioImpact
Frequently asked questions
- Who is Ansbert Gadicke, M.D.?
- Chairman of MPM BioImpact with medical doctorate, involved in identifying and leading transformative therapeutic investments.
- Where does Ansbert Gadicke, M.D. work?
- Ansbert Gadicke, M.D. is Chairman of Mpmcapital and Chairman at MPM BioImpact and Board director at Reunion Neuroscience and Board director at Orna Therapeutics Holdings, LLC and Board director at iTeos Therapeutics.
- What companies did Ansbert Gadicke, M.D. found?
- Ansbert Gadicke, M.D. founded Mpmcapital.
Founder mafias
MPM BioImpact mafia11
Also came through, then founded or led a company.
+ 4 more
iTeos Therapeutics mafia4
Also came through, then founded or led a company.
Chiasma mafia3
Also came through, then founded or led a company.
Clinical ink mafia2
Also came through, then founded or led a company.




















